Indeed, NFκB knockdown resulted in a significant decrease in GLI1 expression, and GLI1 knockdown resulted in decreased claudin-low breast cancer and EMT cell lines’ tumorigenicity. This evidence concerns the gene GLI1 and breast carcinoma.